000			02310 a2200637 4500
005			20250513175610.0
264		0	_c19990513
008			199905s 0 0 eng d
022			_a0008-543X
024	7		_a10.1002/(sici)1097-0142(19990415)85:8<1828::aid-cncr25>3.0.co;2-h _2doi
040			_aNLM _beng _cNLM
100	1		_aJuweid, M E
245	0	0	_aPhase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma. _h[electronic resource]
260			_bCancer _cApr 1999
300			_a1828-42 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnimals
650	0	4	_aAntibodies, Anti-Idiotypic _xbiosynthesis
650	0	4	_aAntibodies, Monoclonal _xpharmacokinetics
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntigens, Neoplasm _ximmunology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCalcitonin _xblood
650	0	4	_aCarcinoembryonic Antigen _ximmunology
650	0	4	_aCarcinoma, Medullary _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoconjugates _xpharmacokinetics
650	0	4	_aIodine Radioisotopes _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aMice
650	0	4	_aMiddle Aged
650	0	4	_aNeck Dissection
650	0	4	_aNeoplasm Proteins _xblood
650	0	4	_aRadioimmunotherapy
650	0	4	_aRadiotherapy Dosage
650	0	4	_aThyroid Neoplasms _xdrug therapy
650	0	4	_aThyroidectomy
650	0	4	_aTissue Distribution
650	0	4	_aTreatment Outcome
700	1		_aHajjar, G
700	1		_aSwayne, L C
700	1		_aSharkey, R M
700	1		_aSuleiman, S
700	1		_aHerskovic, T
700	1		_aPereira, M
700	1		_aRubin, A D
700	1		_aGoldenberg, D M
773	0		_tCancer _gvol. 85 _gno. 8 _gp. 1828-42
856	4	0	_uhttps://doi.org/10.1002/(sici)1097-0142(19990415)85:8<1828::aid-cncr25>3.0.co;2-h _zAvailable from publisher's website
999			_c10182710 _d10182710